Abrogating Phosphorylation of eIF4B Is Required for EGFR and mTOR Inhibitor Synergy in Triple-Negative Breast Cancer
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-014-3102-8
Full Text
Open PDFAbstract
Available in full text
Date
August 17, 2014
Authors
Publisher
Springer Science and Business Media LLC